Cargando…

Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening

BACKGROUND: Establishing a high-accuracy and non-invasive method is essential for evaluating cardiovascular disease. Skin cholesterol is a novel marker for assessing the risk of atherosclerosis and can be used as an independent risk factor of early assessment of atherosclerotic risk. METHODS: We pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Jingshu, Hong, Haiou, Zhang, Yang, Tang, Shiqi, Han, Yongsheng, Fang, Zhaohui, Zhang, Yuanzhi, Zhou, Nan, Wang, Quanfu, Liu, Yong, Li, Zhongsheng, Wang, YiKun, Dong, Meili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170999/
https://www.ncbi.nlm.nih.gov/pubmed/34074299
http://dx.doi.org/10.1186/s12938-021-00889-1
_version_ 1783702349962805248
author Ni, Jingshu
Hong, Haiou
Zhang, Yang
Tang, Shiqi
Han, Yongsheng
Fang, Zhaohui
Zhang, Yuanzhi
Zhou, Nan
Wang, Quanfu
Liu, Yong
Li, Zhongsheng
Wang, YiKun
Dong, Meili
author_facet Ni, Jingshu
Hong, Haiou
Zhang, Yang
Tang, Shiqi
Han, Yongsheng
Fang, Zhaohui
Zhang, Yuanzhi
Zhou, Nan
Wang, Quanfu
Liu, Yong
Li, Zhongsheng
Wang, YiKun
Dong, Meili
author_sort Ni, Jingshu
collection PubMed
description BACKGROUND: Establishing a high-accuracy and non-invasive method is essential for evaluating cardiovascular disease. Skin cholesterol is a novel marker for assessing the risk of atherosclerosis and can be used as an independent risk factor of early assessment of atherosclerotic risk. METHODS: We propose a non-invasive skin cholesterol detection method based on absorption spectroscopy. Detection reagents specifically bind to skin cholesterol and react with indicator to produce colored products, the skin cholesterol content can be obtained through absorption spectrum information on colored products detected by non-invasive technology. Gas chromatography is used to measure cholesterol extracted from the skin to verify the accuracy and reliability of the non-invasive test method. A total of 342 subjects were divided into normal group (n = 115), disease group (n = 110) and risk group (n = 117). All subjects underwent non-invasive skin cholesterol test. The diagnostic accuracy of the measured value was analyzed by receiver-operating characteristic (ROC) curve. RESULTS: The proposed method is able to identify porcine skin containing gradient concentration of cholesterol. The values measured by non-invasive detection method were significantly correlated with gas chromatography measured results (r = 0.9074, n = 73, p < 0.001). Bland–Altman bias was − 72.78 ± 20.03 with 95% limits of agreement − 112.05 to − 33.51, falling within the prespecified clinically non-significant range. We further evaluated the method of patients with atherosclerosis and risk population as well as normal group, patients and risk atherosclerosis group exhibited higher skin cholesterol content than normal group (all P < 0.001). The area under the ROC curve for distinguishing Normal/Disease group was 0.8642 (95% confidence interval, 0.8138 to 0.9146), meanwhile, the area under the ROC curve for distinguishing Normal/Risk group was 0.8534 (95% confidence interval, 0.8034 to 0.9034). CONCLUSIONS: The method demonstrated its capability of detecting different concentration of skin cholesterol. This non-invasive skin cholesterol detection system may potentially be used as a risk assessment tool for atherosclerosis screening, especially for a large population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12938-021-00889-1.
format Online
Article
Text
id pubmed-8170999
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81709992021-06-03 Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening Ni, Jingshu Hong, Haiou Zhang, Yang Tang, Shiqi Han, Yongsheng Fang, Zhaohui Zhang, Yuanzhi Zhou, Nan Wang, Quanfu Liu, Yong Li, Zhongsheng Wang, YiKun Dong, Meili Biomed Eng Online Research BACKGROUND: Establishing a high-accuracy and non-invasive method is essential for evaluating cardiovascular disease. Skin cholesterol is a novel marker for assessing the risk of atherosclerosis and can be used as an independent risk factor of early assessment of atherosclerotic risk. METHODS: We propose a non-invasive skin cholesterol detection method based on absorption spectroscopy. Detection reagents specifically bind to skin cholesterol and react with indicator to produce colored products, the skin cholesterol content can be obtained through absorption spectrum information on colored products detected by non-invasive technology. Gas chromatography is used to measure cholesterol extracted from the skin to verify the accuracy and reliability of the non-invasive test method. A total of 342 subjects were divided into normal group (n = 115), disease group (n = 110) and risk group (n = 117). All subjects underwent non-invasive skin cholesterol test. The diagnostic accuracy of the measured value was analyzed by receiver-operating characteristic (ROC) curve. RESULTS: The proposed method is able to identify porcine skin containing gradient concentration of cholesterol. The values measured by non-invasive detection method were significantly correlated with gas chromatography measured results (r = 0.9074, n = 73, p < 0.001). Bland–Altman bias was − 72.78 ± 20.03 with 95% limits of agreement − 112.05 to − 33.51, falling within the prespecified clinically non-significant range. We further evaluated the method of patients with atherosclerosis and risk population as well as normal group, patients and risk atherosclerosis group exhibited higher skin cholesterol content than normal group (all P < 0.001). The area under the ROC curve for distinguishing Normal/Disease group was 0.8642 (95% confidence interval, 0.8138 to 0.9146), meanwhile, the area under the ROC curve for distinguishing Normal/Risk group was 0.8534 (95% confidence interval, 0.8034 to 0.9034). CONCLUSIONS: The method demonstrated its capability of detecting different concentration of skin cholesterol. This non-invasive skin cholesterol detection system may potentially be used as a risk assessment tool for atherosclerosis screening, especially for a large population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12938-021-00889-1. BioMed Central 2021-06-01 /pmc/articles/PMC8170999/ /pubmed/34074299 http://dx.doi.org/10.1186/s12938-021-00889-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ni, Jingshu
Hong, Haiou
Zhang, Yang
Tang, Shiqi
Han, Yongsheng
Fang, Zhaohui
Zhang, Yuanzhi
Zhou, Nan
Wang, Quanfu
Liu, Yong
Li, Zhongsheng
Wang, YiKun
Dong, Meili
Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening
title Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening
title_full Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening
title_fullStr Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening
title_full_unstemmed Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening
title_short Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening
title_sort development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170999/
https://www.ncbi.nlm.nih.gov/pubmed/34074299
http://dx.doi.org/10.1186/s12938-021-00889-1
work_keys_str_mv AT nijingshu developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT honghaiou developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT zhangyang developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT tangshiqi developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT hanyongsheng developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT fangzhaohui developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT zhangyuanzhi developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT zhounan developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT wangquanfu developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT liuyong developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT lizhongsheng developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT wangyikun developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening
AT dongmeili developmentofanoninvasivemethodforskincholesteroldetectionpreclinicalassessmentinatherosclerosisscreening